| 000 | 00974 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250514001721.0 | ||
| 264 | 0 | _c20010816 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a1523-3804 | ||
| 024 | 7 |
_a10.1007/s11883-001-0022-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEsquenazi, A | |
| 245 | 0 | 0 |
_aBotulinum toxin for the management of muscle overactivity and spasticity after stroke. _h[electronic resource] |
| 260 |
_bCurrent atherosclerosis reports _cJul 2001 |
||
| 300 |
_a295-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aBotulinum Toxins _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMuscle Spasticity _xdrug therapy |
| 650 | 0 | 4 |
_aMuscle, Skeletal _xdrug effects |
| 650 | 0 | 4 |
_aStroke _xcomplications |
| 700 | 1 | _aMayer, N | |
| 773 | 0 |
_tCurrent atherosclerosis reports _gvol. 3 _gno. 4 _gp. 295-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11883-001-0022-y _zAvailable from publisher's website |
| 999 |
_c11320623 _d11320623 |
||